Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,543 followers.

0.16 (very rough estimate.) https://t.co/30S5dW5eLO

New article: Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology https://t.co/JhfB7M5lIS #MS #multiplesclerosis #neurology https://t.co/pswBAS29g4

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.